Notes
The study was funded by AstraZeneca.
Reference
Nielsen R, et al. Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries. Respiratory Medicine : 13 Jul 2013. Available from: URL: http://dx.doi.org/10.1016/j.rmed.2013.06.007
Rights and permissions
About this article
Cite this article
Budesonide/formoterol good value for money in COPD. PharmacoEcon Outcomes News 684, 4 (2013). https://doi.org/10.1007/s40274-013-0599-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0599-8